Virtual Roundtables

Healthcare

AI Under Guardrails: Building the Revenue-Ready Marketing Organization for Digital Health, MedTech, Pharma and Analytical Technology

September 15, 2026 | 1:00 – 2:00 p.m. ET | Virtual

For today’s healthcare and life sciences marketing leaders, the mandate to prove revenue contribution has never been sharper. Yet every AI use case, data flow and campaign must clear a regulatory and compliance bar their peers in other industries never see.

Alexander Group’s Revenue-Ready Marketing Organization research reveals that 74% of organizations have analytics/attribution AI actively deployed or scaled, yet 40% still operate with no formal (or only informal) AI governance and 48% cite data quality as a top three barrier. This combination is especially acute where patient data, HIPAA and promotional review constraints apply.

How can healthcare and life sciences commercial leaders scale AI without tripping compliance and prove marketing’s revenue contribution to the board?

Join Alexander Group’s Marketing practice leaders for this complimentary, virtual roundtable on how the most effective regulated-market organizations are simultaneously redesigning teams for AI under guardrails and proving pipeline economics with new attribution rigor.

Drawing on the new research, this one-hour session will foster candid peer-level discussions on:

  • MLR-safe AI at scale: Deploying generative AI for medical/regulatory content, labeling and field enablement without breaking promotional review discipline.
  • The governance gap: The policy frameworks regulated markets need before scaling AI, and why “deploy first, govern later” fails hardest under promotional review.
  • Attribution in committee-driven buying: Proving contribution when a purchase runs through clinicians, procurement, compliance and finance—and 70% of evaluation happens before sales ever engage.
  • Enterprise unit economics: Managing $15K+ CAC and sub-12-month payback pressure in device, diagnostic and platform sales.
  • Customer-led growth: Why 33% of high-growth orgs are investing in customer journey architecture and content strategy to drive retention and expansion.

Leaders will walk away with: 

  • A governed-AI adoption model tuned for MLR, HIPAA and promotional-review realities, so you can scale without slowing.
  • Marketing-sourced pipeline and attribution benchmarks specific to healthcare and life sciences buying cycles.
  • Enterprise CAC, LTV:CAC and payback benchmarks to reframe your next board and CFO conversation.
  • A shared CMO–CRO language for aligning demand quality, seller coverage and forecast confidence.
  • Priority access to the Revenue-Ready self-diagnostic as well as the healthcare- and life sciences-specific briefings.

Who Should Attend 

CMOs, CROs, CCOs and SVPs/VPs of Marketing and Sales at digital health, MedTech, medical device, biotech/pharma, pharma services, health insurance and analytical technology organizations.

Attendance is limited and curated to protect candor.

Register Now